| Phase 4 |
| NCT07674368 |
Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed |
ALK Fusion-positive Non-small Cell Lung Cancer |
Not Yet Recruiting |
| Phase 3 |
| NCT06840704 |
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer |
Non Small Cell Lung Cancer |
Recruiting |
| Phase 2 |
| NCT05940532 |
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC |
Carcinoma, Non-Small-Cell Lung |
Recruiting |
| NCT06385990 |
Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy |
Triple Negative Breast Neoplasms |
Recruiting |
| NCT06406634 |
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy… |
Hepatocellular Carcinoma |
Recruiting |
| NCT06752798 |
Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC |
Head and Neck Cancer Squamous Cell Carcinoma |
Recruiting |
| NCT06788002 |
LDRT and Chemoimmunotherapy in NPC With Liver Metastasis |
Nasopharyngeal Cancinoma (NPC) |
Recruiting |
| NCT07314216 |
Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR… |
NSCLC (Non-small Cell Lung Carcinoma) |
Recruiting |
| NCT06327698 |
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or… |
Melanoma |
Not Yet Recruiting |
| NCT07083687 |
Lorlatinib in ROS1+ NSCLC With Brain Metastasis |
Lung Cancer (NSCLC) |
Not Yet Recruiting |
| NCT07627620 |
Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/… |
Cervical Cancer |
Not Yet Recruiting |
| Phase 1/2 |
| NCT05535413 |
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With… |
Metastatic HER2 Negative Breast Carcinoma |
Recruiting |
| Phase 1 |
| NCT07163481 |
A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in… |
Stage IV (Metastatic) Breast Cancer |
Not Yet Recruiting |
| Not specified |
| NCT05326295 |
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in… |
Breast Neoplasms |
Recruiting |
| NCT06321939 |
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT06543108 |
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in… |
Gastric Cancer |
Recruiting |
| NCT06557590 |
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors |
Cancer |
Recruiting |
| NCT06734533 |
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+）… |
HR+ Breast Cancer |
Recruiting |
| NCT06033287 |
Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent… |
Breast Cancer |
Recruiting |
| NCT07073755 |
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer… |
Metastatic Breast Cancer |
Recruiting |
| NCT07098026 |
Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced… |
Gastric Cancer, Adenocarcinoma |
Recruiting |
| NCT05980208 |
A Real-world Study of Inetetamab for First-line Treatment of MBC |
Breast Cancer |
Not Yet Recruiting |
| NCT06748495 |
Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell… |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
Active, Not Recruiting |
| NCT07676383 |
Precision Navigation to Improve Community Cancer Screening Participation |
Cancer Screening |
Not Yet Recruiting |